Skip to content

Pilot Study „Digitaler Nichtraucherkurs nach Dr. med. Stefan Frädrich“

Pilot Study „Digitaler Nichtraucherkurs nach Dr. med. Stefan Frädrich“ - PS-DNR

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00030582
Enrollment
80
Registered
2022-10-28
Start date
2022-11-28
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F17.2

Interventions

Group 1: The intervention group receives a 3-minute “brief advice” by a medical pracitioner and uses the digital application. Group 2: The control group receives only a 3-minute “brief advice” by a me

Sponsors

DiA42 - Gesellschaft für digitale Medizinprodukte mbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - ICD-10 F17.2 (Mental and behavioural disorders due to use of tobacco: dependence syndrome) diagnosed by a medical practitioner - Openness to stop smoking - Age = 18 years - Digital device to use the application - Place of residence: Federal Republic of Germany - Valid personal E-Mail address

Exclusion criteria

Exclusion criteria: - Additional abuse of alcohol, medications or illegal drugs - Acute symptomatic psychiatric diseases - Acute symptomatic neurological diseases - Severe cognitive limitations - Dementia - Visual impairment which prevents the correct utilization of the application - Limited ability to understand German - Current participation in another, non-digital programme to support smoking abstinence - Utilization of another digital application to support smoking abstinence

Design outcomes

Secondary

MeasureTime frame
Smoking abstinence after 4 weeks, based on a 7-day prevalence; Smoking abstinence after 12 weeks, based on a prolonged abstinence (including a two-week grace period); Reduction in the use of nicotine-containing products after 12 weeks; Health-related quality of life (SF-12) after 12 weeks; Self-efficacy (SER) after 12 weeks; Coughing (based on a modified COPD-scale) after 12 weeks; Dyspnoe (mMRC-Dyspnoeskala) after 12 weeks.

Primary

MeasureTime frame
Smoking abstinence after 12 weeks, based on a 7-day prevalence.

Countries

Germany

Contacts

Public ContactJens Geißler

DiA42 - Gesellschaft für digitale Medizinprodukte mbH

info@dia42.de+491784157145

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026